Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avitas CBD Water, LLC was a Portland, Oregon-based company that developed and marketed CBD-infused bottled water for the mainstream retail market. The company's flagship product, Avitas CBD Water, was notable for utilizing CBD that was not derived from hemp or marijuana, enabling distribution through traditional grocery and convenience store channels. In March 2018, the company formed a strategic partnership with Xanthic Biopharma Inc., which acquired a 45% ownership stake in the business. Following this investment, Avitas CBD Water was rebranded as Xanthic Beverages, and its primary product was renamed Xanthic CBD Water. The rebranded products integrated Xanthic's proprietary water-solubility technology, which was designed to improve the bioavailability and onset time of cannabinoids. The company's distribution network included over 500 retail locations across Eastern Washington and Northeast Oregon, supported by a PepsiCo-contracted bottling partner.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avitas CBD Water.